| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.006 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |